SEOUL, South Korea, Jan. 30, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic technologies, announces that , marking another major milestone in the global expansion of its advanced fractional resurfacing platform.
Following its successful launch in selected international markets, Mosaic 3D™ continues to gain strong momentum, driven by positive clinical adoption and growing interest from leading experts worldwide.
Mosaic 3D™ represents the next generation of non-ablative fractional laser, offering to deliver more energy and cover more areas, whilst ensuring safety with minimal discomfort and downtime for patients through:
Mosaic 3D™ is currently being used in clinical practice and investigator-led studies by internationally recognized experts, including , , and .
Dr Guy Erlich commented:
Professor Merete Haedersdal added:
"Our clinical study with Mosaic™ 3D on how imaging analyses have allowed us to gain a better understanding of laser-tissue interactions with Mosaic3D to optimize treatment protocols for our patients - has generated very promising results. The data is currently being finalised for publication, and I look forward to presenting our findings to the international medical community at IMCAS 2026."
Dr Tatiana Kuznechenkova stated:
Mosaic 3D™
Building on its EU MDR approval and successful launches in other regions, Mosaic 3D™ will be a key highlight at the , where Cynosure Lutronic will host a dedicated scientific symposium led by Dr Guy Erlich and Professor Merete Haedersdal: ™, The symposium will be held on Friday January 30 at 15:45pm, Room 351 on Level 3. It will focus on clinical data, treatment protocols, and real-world experience with Mosaic 3D™, supported by additional educational and scientific activities throughout the congress.
Cynosure Lutronic remains committed to advancing evidence-based innovation and delivering next-generation technologies that empower healthcare professionals and elevate patient outcomes worldwide.
With over 30 years of combined innovation and leadership in energy-based devices, Cynosure Lutronic enables dermatologists, plastic surgeons, and aesthetic practitioners worldwide to deliver non-invasive and minimally invasive treatments. The company offers one of the industry's most comprehensive portfolios across skin resurfacing, revitalisation, hair removal, vascular treatments, skin toning, and body contouring. Cynosure Lutronic operates through direct sales in the United States, Canada, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through distributors in approximately 130 countries worldwide.
Fleur RequenaMarketing Director EMEA & LATAM
Logo - Photo -
View original content to download multimedia: https://www.prnewswire.co.uk/news-releases/cynosure-lutronic-announces-completion-of-eu-mdr-approval-and-global-momentum-for-mosaic-3d-ahead-of-imcas-2026-302675325.html